Transarterial Chemoembolization (TACE) for Inoperable Intrahepatic Cholangiocarcinoma (original) (raw)
Anderson CD, Pinson CW, Berlin J, et al. (2004) Diagnosis and treatment of cholangiocarcinoma. Oncologist 9(1):43–57 ArticlePubMed Google Scholar
Khan S, Howard CT, Davidson BR, et al. (2005) Cholangiocarcinoma. Lancet 366:1303–1314 ArticlePubMed Google Scholar
Olnes MJ, Erlich R (2004) A review and update on cholangiocarcinoma. Oncology 66(3):167–179 ArticlePubMed Google Scholar
Farley DR, Weaver AL, Nagorney DM (1995) “Natural history” of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 70(5):425–429 ArticlePubMedCAS Google Scholar
Heimbach JK, Gores GJ, Haddock MG, et al. (2004) Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 24(2):201–207 ArticlePubMed Google Scholar
Llovet JM, Real MI, Montana X, et al. Barcelona Liver Cancer Group (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359(9319):1734–1739 ArticlePubMed Google Scholar
Lo CM, Ngan H, Tso WK, et al. (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35(5):1164–1171 ArticlePubMedCAS Google Scholar
Burger I, Hong K, Schulick R, et al. (2005) Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol 16(3):353–361 PubMed Google Scholar
Huppert PE, Lauchart W, Duda S, et al. (2004) Chemoembolisation des hepatozellulären Karzinoms: Welche Faktoren bestimmen Therapieansprechen und Überleben? Fortschr Röntgenstr 176:375–385 ArticleCAS Google Scholar
Therasse P (2002) Measuring the clinical response. What does it mean? Eur J Cancer 38(14):1817–1823 ArticlePubMedCAS Google Scholar
Sacks D, McClenny TE, Cardella JF, et al. (2003) Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14(9; Pt 2):S199–S202 PubMed Google Scholar
Ikeda M, Okusaka T, Ueno H, Morizane C, Furuse J, Ishii H (2005) A phase II trial of uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma. Jpn J Clin Oncol 35(8):439–443 ArticlePubMed Google Scholar
Okusaka T, Ishii H, Funakoshi A, et al. (2006) Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol 57(5):647–653 ArticlePubMedCAS Google Scholar
Kornek GV, Schuell B, Laengle F, et al. (2004) Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. Ann Oncol 15(3):478–483 ArticlePubMedCAS Google Scholar
Raderer M, Hejna MH, Valencak JB, et al. (1999) Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer. Oncology 56(3):177–180 ArticlePubMedCAS Google Scholar
Penz M, Kornek GV, Raderer M, et al. (2001) Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol 12(2):183–186 ArticlePubMedCAS Google Scholar
Marelli L, Stigliano R, Triantos C, et al. (2007) Transarterial therapy for hepatocellular carcinoma: Which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30(1):6–25 Google Scholar
Malhi H, Gores GJ (2006) Review article: the modern diagnosis and therapy of cholangiocarcinoma. Aliment Pharmacol Ther 23(9):1287–1296 ArticlePubMedCAS Google Scholar
Hejna M, Pruckmayer M, Raderer M (1998) The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer 34(7):977–986 ArticlePubMedCAS Google Scholar
Todoroki T (2000) Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery. Hepatogastroenterology 47(33):644–649 PubMedCAS Google Scholar
Herber S, Schneider J, Brecher B, et al. (2005) TACE: therapy of the HCC before liver transplantation—experiences. Fortschr Röntgenstr 177(5):681–690 [in German] ArticleCAS Google Scholar
Otto G, Herber S, Heise M, et al. (2006) Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 12(8):1260–1267 ArticlePubMed Google Scholar
Kirchhoff T, Zender L, Merkesdal S, et al. (2005) Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver. World J Gastroenterol 11(8):1091–1095 PubMed Google Scholar
Vogl TJ, Schwarz W, Eichler K, et al. (2006) Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy. J Cancer Res Clin Oncol 132(11):745–755 ArticlePubMedCAS Google Scholar
Tanaka N, Yamakado K, Nakatsuka A, et al. (2002) Arterial chemoinfusion therapy through an implanted port system for patients with unresectable intrahepatic cholangiocarcinoma—initial experience. Eur J Radiol 41(1):42–48 ArticlePubMed Google Scholar
Choi BI, Kim HC, Han JK, et al. (1992) Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 182(3):709–713 PubMedCAS Google Scholar
Eurvilaichit C (2004) Outcome of transcatheter oily chemoembolization in patients with hepatocellular carcinoma. Hepatogastroenterology 51(55):20–24 PubMed Google Scholar
Shimada M, Takenaka K, Kawahara N, et al. (1996) Chemosensitivity in primary liver cancers: evaluation of the correlation between chemosensitivity and clinicopathological factors. Hepatogastroenterology 43(11):1159–1164 PubMedCAS Google Scholar
Lee GW, Kang JH, Kim HG, et al. (2006) Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma. Am J Clin Oncol 29(2):127–131 ArticlePubMedCAS Google Scholar
Asakura H, Ohtsuka M, Ito H, et al. (2005) Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis. Hepatogastroenterology 52(63):722–724 PubMed Google Scholar
Heron DE, Stein DE, Eschelman DJ, et al. (2003) Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome. Am J Clin Oncol 26(4):422–428 ArticlePubMed Google Scholar
Park SH, Park YH, Lee JN, et al. (2006) Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinomas. Cancer 106(2):361–365 ArticlePubMedCAS Google Scholar
Knox JJ, Hedley D, Oza A, et al. (2005) Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol 23(10):2332–2338 ArticlePubMedCAS Google Scholar
Papakostas P, Kouroussis C, Androulakis, et al. (2001) First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study. Eur J Cancer 37(15):1833–1838 ArticlePubMedCAS Google Scholar